Evaluation of Fis-۱ and miR-۴۸۴ Expression Levels in Tumor Tissue Samples and Healthy Tumor Margins in Lung Cancer

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: English
View: 71

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_MISJ-15-1_001

تاریخ نمایه سازی: 16 دی 1402

Abstract:

Background: MicroRNAs (miRNAs) regulate gene expression and various cellular activities. They also hold significant importance in the progression and development of human malignancies. Among these, miRNA-۴۸۴ and the Fis-۱ gene have been identified as having substantial roles in lung cancer. This study aims to ascertain miRNA-۴۸۴ and Fis-۱ gene expression levels in non-small cell lung cancer (NSCLC) patients.Method: In this case-control study, ۴۵ pairs of tumor tissues and their corresponding healthy margin tissues were surgically obtained from NSCLC patients and promptly preserved in liquid nitrogen after excision. Total RNA extraction was performed using TRIzol, followed by cDNA synthesis using a designated kit. Afterward, we used quantitative reverse transcription polymerase chain reaction (qRT-PCR) to measure the expression levels of miRNA-۴۸۴ and the Fis-۱ gene. Furthermore, the clinicopathological characteristics of the NSCLC patients were assessed.Results: Our findings revealed an upregulation of miRNA-۴۸۴ expression and downregulation of Fis-۱ gene expression in NSCLC tissues compared with non-tumor tissues. Additionally, significant correlations were observed between miRNA-۴۸۴ and Fis-۱ gene expression levels and clinicopathological features of the patients, including factors such as lymph node involvement and distant metastasis.Conclusion: These findings suggest the potential utility of Fis-۱ and miR-۴۸۴ as prognostic and diagnostic markers in NSCLC.

Authors

Leila Namvar

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Mehdi Nadiri

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Zahra Mohebbi

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Milad Asadi

Department of Basic Oncology, Ege University, Institute of Health Sciences, Izmir, Turkey

Maryam Seyyedi

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Amir Amiri-Sadeghan

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Zahra Soleimani

Rahat Breathe and Sleep Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Shahriyar Hashemzadeh

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Yeganeh Khalili

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Habib Zarredar

Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Zarredar H, Ansarin K, Baradaran B, Ahdi Khosroshahi S, Farajnia ...
  • Yuan M, Huang LL, Chen JH, Wu J, Xu Q. ...
  • Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, ...
  • Frank S, Gaume B, Bergmann-Leitner ES, Leitner WW, Robert EG, ...
  • Ihenacho UK, Meacham KA, Harwig MC, Widlansky ME, Hill RB. ...
  • Serasinghe MN, Wieder SY, Renault TT, Elkholi R, Asciolla JJ, ...
  • Lee S, Park YY, Kim SH, Nguyen OTK, Yoo YS, ...
  • Zarredar H, Ansarin K, Baradaran B, Shekari N, Eyvazi S, ...
  • Zarredar H, Farajnia S, Ansarin K, Baradaran B, Aria M, ...
  • Ye FG, Song CG, Cao ZG, Xia C, Chen DN, ...
  • Guo X, Han T, Hu P, Guo X, Zhu C, ...
  • Daryabari SS, Safaralizadeh R, Hosseinpourfeizi M, Moaddab Y, Shokouhi B. ...
  • Zarredar H, Pashapour S, Farajnia S, Ansarin K, Baradaran B, ...
  • Wang Z, Liu Z, Fang X, Yang H. MiR-۱۴۲-۵p suppresses ...
  • Zhuang Z, Sun C, Gong H. High serum miR-۴۸۴ expression ...
  • Yang Y, Lin X, Lu X, Luo G, Zeng T, ...
  • Mei Q, Xue G, Li X, Wu Z, Li X, ...
  • Pashaei E, Pashaei E, Ahmady M, Ozen M, Aydin N. ...
  • Lee D, Tang W, Dorsey TH, Ambs S. miR-۴۸۴ is ...
  • Li T, Ding ZL, Zheng YL, Wang W. MiR-۴۸۴ promotes ...
  • Li Y, Liu Y, Yao J, Li R, Fan X. ...
  • Lin X, Li J, Yin G, Zhao Q, Elias D, ...
  • Yamamori T, Ike S, Bo T, Sasagawa T, Sakai Y, ...
  • Jin X, Zheng X, Li F, Liu B, Li H, ...
  • Hsiao CP, Wang D, Kaushal A, Chen MK, Saligan L. ...
  • Wang K, Long B, Jiao JQ, Wang JX, Liu JP, ...
  • Karimi D, Pedram N, Kakaei F, Asadi M, Poursaei E, ...
  • نمایش کامل مراجع